LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

Search

Perrigo Co PLC

Ouvert

SecteurSoins de santé

26.96 2.78

Résumé

Variation du prix de l'action

24h

Actuel

Min

26.25

Max

26.98

Chiffres clés

By Trading Economics

Revenu

38M

-6.4M

Ventes

-94M

1B

P/E

Moyenne du Secteur

2,570

56.602

BPA

0.6

Rendement du dividende

4.29

Marge bénéficiaire

-0.613

Employés

8,379

EBITDA

13M

127M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+30.28% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.29%

2.45%

Prochains Résultats

1 août 2025

Date du Prochain Dividende

17 juin 2025

Date du Prochain Détachement de Dividende

30 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

349M

3.7B

Ouverture précédente

24.18

Clôture précédente

26.96

Sentiment de l'Actualité

By Acuity

15%

85%

18 / 382 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Perrigo Co PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 févr. 2025, 17:42 UTC

Principaux Mouvements du Marché

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27 févr. 2025, 23:52 UTC

Résultats

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Comparaison

Variation de prix

Perrigo Co PLC prévision

Objectif de Prix

By TipRanks

30.28% hausse

Prévisions sur 12 Mois

Moyen 34.25 USD  30.28%

Haut 42 USD

Bas 27 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

2

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

25.22 / 26.85Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

18 / 382Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.